TNFRSF9 and interstitial lung disease: Comparing baseline ILD scoring and outcome in our study demonstrated that more individuals with baseline ILA scores of 0, 1, and 2 were in the no-progression group (41/58 individuals with ILA 0–2 did not progress) relative to those individuals with a baseline ILA score of 3 (where both patients progressed).